|
1
|
Lai KN: Pathogenesis of IgA nephropathy.
Nat Rev Nephrol. 8:275–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGrogan A, Franssen CF and de Vries CS:
The incidence of primary glomerulonephritis worldwide: A systematic
review of the literature. Nephrol Dial Transplant. 26:414–430.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mestecky J, Novak J, Moldoveanu Z and
Raska M: IgA nephropathy enigma. Clin Immunol. 172:72–77. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boyd JK, Cheung CK, Molyneux K, Feehally J
and Barratt J: An update on the pathogenesis and treatment of IgA
nephropathy. Kidney Int. 81:833–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu H, Wu K, Yan W, Hu L, Yuan J, Dong Y,
Li Y, Jing K, Yang Y and Guo M: Epigenetic silencing of DACH1
induces loss of transforming growth factor-β1 antiproliferative
response in human hepatocellular carcinoma. Hepatology.
58:2012–2022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Popov VM, Wu K, Zhou J, Powell MJ, Mardon
G, Wang C and Pestell RG: The Dachshund gene in development and
hormone-responsive tumorigenesis. Trends Endocrinol Metab.
21:41–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ikeda K, Watanabe Y, Ohto H and Kawakami
K: Molecular interaction and synergistic activation of a promoter
by Six, Eya, and Dach proteins mediated through CREB binding
protein. Mol Cell Biol. 22:6759–6766. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu QQ, Zhou YQ, Liu HQ, Qiu WH, Liu H, Hu
TY, Xu Q, Lv YM and Wu KM: Decreased DACH1 expression in
glomerulopathy is associated with disease progression and severity.
Oncotarget. 7:86547–86560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sunde JS, Donninger H, Wu K, Johnson ME,
Pestell RG, Rose GS, Mok SC, Brady J, Bonome T and Birrer MJ:
Expression profiling identifies altered expression of genes that
contribute to the inhibition of transforming growth factor-beta
signaling in ovarian cancer. Cancer Res. 66:8404–8412. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu K, Li A, Rao M, Liu M, Dailey V, Yang
Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, et al: DACH1 is a cell
fate determination factor that inhibits cyclin D1 and breast tumor
growth. Mol Cell Biol. 26:7116–7129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dalgin GS, Drever M, Williams T, King T,
DeLisi C and Liou LS: Identification of novel epigenetic markers
for clear cell renal cell carcinoma. J Urol. 180:1126–1130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamada Y, Arao T, Gotoda T, Taniguchi H,
Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, et al:
Identification of prognostic biomarkers in gastric cancer using
endoscopic biopsy samples. Cancer Sci. 99:2193–2199. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen R, Amoui M, Zhang Z and Mardon G:
Dachshund and eyes absent proteins form a complex and function
synergistically to induce ectopic eye development in Drosophila.
Cell. 91:893–903. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen W and Mardon G: Ectopic eye
development in Drosophila induced by directed dachshund expression.
Development. 124:45–52. 1997.PubMed/NCBI
|
|
15
|
Fan GK, Imanaka M, Yang B and Takenaka H:
Characteristics of nasal inverted papilloma and its malignant
transformation: A study of cell proliferation and programmed cell
death. Am J Rhinol. 20:360–363. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu M, Zhang H, Li Y, Wang R, Li Y, Zhang
H, Ren D, Liu H, Kang C and Chen J: HOTAIR, a long noncoding RNA,
is a marker of abnormal cell cycle regulation in lung cancer.
Cancer Sci. 109:2717–2733. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Dong M, Cui J, Xu F, Yan C, Ma C,
Yi L, Tang W, Dong J and Wei Y: NME4 may enhance nonsmall cell lung
cancer progression by overcoming cell cycle arrest and promoting
cellular proliferation. Mol Med Rep. 20:1629–1636. 2019.PubMed/NCBI
|
|
18
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang
J, Ertel A, Li Z, Rui H, Quong A, et al: Dachshund binds p53 to
block the growth of lung adenocarcinoma cells. Cancer Res.
73:3262–3274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalousova A, Mavropoulos A, Adams BA,
Nekrep N, Li Z, Krauss S, Stainier DY and German MS: Dachshund
homologues play a conserved role in islet cell development. Dev
Biol. 348:143–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li K, Du Y, Jiang BL and He JF: Increased
microRNA-155 and decreased microRNA-146a may promote ocular
inflammation and proliferation in Graves' ophthalmopathy. Med Sci
Monit. 20:639–643. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
miR-138 induces cell cycle arrest by targeting cyclin D3 in
hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tamouza H, Vende F, Tiwari M,
Arcos-Fajardo M, Vrtovsnik F, Benhamou M, Monteiro RC and Moura IC:
Transferrin receptor engagement by polymeric IgA1 induces receptor
expression and mesangial cell proliferation: Role in IgA
nephropathy. Contrib Nephrol. 157:144–147. 2007.PubMed/NCBI
|
|
27
|
Lai KN, To WY, Li PK and Leung JC:
Increased binding of polymeric lambda-IgA to cultured human
mesangial cells in IgA nephropathy. Kidney Int. 49:839–845. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schena FP and Nistor I: Epidemiology of
IgA nephropathy: A global perspective. Semin Nephrol. 38:435–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tian J, Wang Y, Liu X, Zhou X and Li R:
Rapamycin ameliorates IgA nephropathy via cell cycle-dependent
mechanisms. Exp Biol Med (Maywood). 240:936–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kurogi Y: Mesangial cell proliferation
inhibitors for the treatment of proliferative glomerular disease.
Med Res Rev. 23:15–31. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rodrigues JC, Haas M and Reich HN: IgA
nephropathy. Clin J Am Soc Nephrol. 12:677–686. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leung JC, Chan LY, Tang SC, Lam MF, Chow
CW, Lim AI and Lai KN: Oxidative damages in tubular epithelial
cells in IgA nephropathy: Role of crosstalk between angiotensin II
and aldosterone. J Transl Med. 9:1692011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morgan DO: Principles of CDK regulation.
Nature. 374:131–134. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JK and Diehl JA: Nuclear cyclin D1: An
oncogenic driver in human cancer. J Cell Physiol. 220:292–296.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wolf G and Shankland SJ: Cell cycle
control in glomerular disease. Prog Cell Cycle Res. 5:71–79.
2003.PubMed/NCBI
|
|
37
|
Shankland SJ and Wolf G: Cell cycle
regulatory proteins in renal disease: Role in hypertrophy,
proliferation, and apoptosis. Am J Physiol Renal Physiol.
278:F515–F529. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Liu Z, Guo X, Shu J, Chen Z and Li
L: Aristolochic acid I-induced DNA damage and cell cycle arrest in
renal tubular epithelial cells in vitro. Arch Toxicol. 80:524–532.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Marshall CB and Shankland SJ: Cell cycle
and glomerular disease: A minireview. Nephron Exp Nephrol.
102:e39–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dai Y, Sui W, Lan H, Yan Q, Huang H and
Huang Y: Microarray analysis of micro-ribonucleic acid expression
in primary immunoglobulin A nephropathy. Saudi Med J. 29:1388–1393.
2008.PubMed/NCBI
|
|
41
|
Silveri L, Tilly G, Vilotte JL and Le
Provost F: MicroRNA involvement in mammary gland development and
breast cancer. Reprod Nutr Dev. 46:549–556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Khoshnaw SM, Green AR, Powe DG and Ellis
IO: MicroRNA involvement in the pathogenesis and management of
breast cancer. J Clin Pathol. 62:422–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
